Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Healthtech SMEs Voice The Challenges They Face In The Market

Multi-part program to help companies navigate the regulatory maze

Executive Summary

A multi-stakeholder research and funding program led by deeptech innovation organization CPI has produced two UK medtech industry outlook reports and overseen a £7m innovation funding scheme. Training to help SMEs navigate their way through the medtech regulatory maze is another part the program, the findings of which were released to the public this month.

You may also be interested in...

Medtech SMEs Set Out Regulatory Needs As UK Advances Post-EU System

While the UK continues to develop the future medtech regulatory system for Great Britain, a new market access report recommends how the MHRA should simplify regulatory processes for SMEs.

Route To Better IVD Commercial Opportunities Outlined In UK Roadmap

The COVID-19 pandemic put disease diagnosis in the spotlight for the public and national health care systems alike. A UK report highlights how the IVD industry must capitalize on this unique moment in time.

MHRA Grants Extra Year For CE-Marked Devices To Access UK Market

The UK regulator is likely to establish mid-2024 as the new deadline for the standstill period during which CE-marked devices may access the UK market. Compulsory UKCA marking would accordingly also be delayed by a year.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts